179 related articles for article (PubMed ID: 38130922)
1. Reduction of SARS-CoV-2 viral load in saliva after rinsing with mouthwashes containing cetylpyridinium chloride: a randomized clinical study.
Bezinelli LM; Corrêa L; Beyerstedt S; Franco ML; Rangel ÉB; Benítez CG; Hamerschlak N; Pinho JRR; Heller D; Eduardo FP
PeerJ; 2023; 11():e15080. PubMed ID: 38130922
[TBL] [Abstract][Full Text] [Related]
2. Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial.
Eduardo FP; Corrêa L; Heller D; Daep CA; Benitez C; Malheiros Z; Stewart B; Ryan M; Machado CM; Hamerschlak N; Rebello Pinho JR; Bezinelli LM
Heliyon; 2021 Jun; 7(6):e07346. PubMed ID: 34189331
[TBL] [Abstract][Full Text] [Related]
3. Oral mouthwashes for asymptomatic to mildly symptomatic adults with COVID-19 and salivary viral load: a randomized, placebo-controlled, open-label clinical trial.
Onozuka D; Takatera S; Matsuo H; Yoshida H; Hamaguchi S; Yamamoto S; Sada RM; Suzuki K; Konishi K; Kutsuna S
BMC Oral Health; 2024 Apr; 24(1):491. PubMed ID: 38664718
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.
Seneviratne CJ; Balan P; Ko KKK; Udawatte NS; Lai D; Ng DHL; Venkatachalam I; Lim KS; Ling ML; Oon L; Goh BT; Sim XYJ
Infection; 2021 Apr; 49(2):305-311. PubMed ID: 33315181
[TBL] [Abstract][Full Text] [Related]
5. An exploratory study of drug concentration and inhibitory effect of cetylpyridinium chloride buccal tablets on SARS-CoV-2 infection among 10 Chinese subjects.
Li Y; Xie Z; Chen L; Liu X; Li S; Ye S; Tang H; Lee C; Gu Q; Men F; Zhang J; Hu D; Jiang Y; Wang X; Wang Q; Feng Y; Niu S; Liu Y; Fang Y
Fundam Clin Pharmacol; 2024 Jun; 38(3):579-587. PubMed ID: 37985697
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot study.
Perussolo J; Teh MT; Gkranias N; Tiberi S; Petrie A; Cutino-Moguel MT; Donos N
Sci Rep; 2023 Aug; 13(1):12647. PubMed ID: 37542087
[TBL] [Abstract][Full Text] [Related]
7. Randomized clinical trial to assess the impact of oral intervention with cetylpyridinium chloride to reduce salivary SARS-CoV-2 viral load.
Tarragó-Gil R; Gil-Mosteo MJ; Aza-Pascual-Salcedo M; Alvarez MJL; Ainaga RR; Gimeno NL; Viñuales RF; Fernández YM; Marco JM; Bolsa EA; Sancho JB; Cajo SA; Perez-Zsolt D; Raïch-Regué D; Muñoz-Basagoiti J; Izquierdo-Useros N; Pociello VB; León R; Peris DS
J Clin Periodontol; 2023 Mar; 50(3):288-294. PubMed ID: 36345827
[TBL] [Abstract][Full Text] [Related]
8. Cetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial.
Alemany A; Perez-Zsolt D; Raïch-Regué D; Muñoz-Basagoiti J; Ouchi D; Laporte-Villar C; Baro B; Henríquez N; Prat N; Gianinetto MO; Gutiérrez MV; Sánchez-Paniagua MG; Henríquez NL; Vicente JM; Ara J; Rodriguez-Arias MA; Puig J; Blanco I; Lopez CC; Hernández Á; Bordoy AE; Redondo CE; Soler VG; Giménez M; Blanc V; León R; Gispert J; ; Clotet B; Izquierdo-Useros N; Mitjà O
J Dent Res; 2022 Nov; 101(12):1450-1456. PubMed ID: 35727681
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Cetylpyridinium Chloride mouthwash against SARS-CoV-2: A systematic review of randomized controlled trials.
D'Amico F; Moro M; Saracino M; Marmiere M; Cilona MB; Lloyd-Jones G; Zangrillo A
Mol Oral Microbiol; 2023 Jun; 38(3):171-180. PubMed ID: 36808889
[TBL] [Abstract][Full Text] [Related]
10. Eligibility and efficacy of a CPC- and CHX-based antiviral mouthwash for the elimination of SARS-CoV-2 from the saliva: A randomized, double-blind, controlled clinical trial.
Brunello G; Wolf V; Kerberger R; Bernhard M; Lübke N; Becker J; Schwarz-Herzke B; Timm J; Becker K
J Clin Periodontol; 2024 Feb; 51(2):158-166. PubMed ID: 38058254
[TBL] [Abstract][Full Text] [Related]
11. CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva.
Anderson ER; Patterson EI; Richards S; Pitol AK; Edwards T; Wooding D; Buist K; Green A; Mukherjee S; Hoptroff M; Hughes GL
J Med Microbiol; 2022 Feb; 71(2):. PubMed ID: 35180046
[No Abstract] [Full Text] [Related]
12. Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial.
Sánchez Barrueco Á; Mateos-Moreno MV; Martínez-Beneyto Y; García-Vázquez E; Campos González A; Zapardiel Ferrero J; Bogoya Castaño A; Alcalá Rueda I; Villacampa Aubá JM; Cenjor Español C; Moreno-Parrado L; Ausina-Márquez V; García-Esteban S; Artacho A; López-Labrador FX; Mira A; Ferrer MD
Emerg Microbes Infect; 2022 Dec; 11(1):1833-1842. PubMed ID: 35796097
[TBL] [Abstract][Full Text] [Related]
13. Mouth rinses efficacy on salivary SARS-CoV-2 viral load: A randomized clinical trial.
Alzahrani MM; Bamashmous S; Alkharobi H; Alghamdi A; Alharbi RH; Hassan AM; Darwish M; Bukhari A; Mahmoud AB; Alfaleh MA; Mirza AA; Abuzenadah AM; Abujamel TS; Hashem AM
J Med Virol; 2023 Jan; 95(1):e28412. PubMed ID: 36527332
[TBL] [Abstract][Full Text] [Related]
14. A clinical study to assess the 12-hour antimicrobial effects of cetylpyridinium chloride mouthwashes on supragingival plaque bacteria.
He S; Wei Y; Fan X; Hu D; Sreenivasan PK
J Clin Dent; 2011; 22(6):195-9. PubMed ID: 22403975
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a Mouthwash Containing CHX and CPC in SARS-CoV-2-Positive Patients: A Randomized Controlled Clinical Trial.
Bonn EL; Rohrhofer A; Audebert FX; Lang H; Auer DL; Scholz KJ; Schuster P; Wenzel JJ; Hiller KA; Buchalla W; Gottsauner JM; Vielsmeier V; Schmidt B; Cieplik F
J Dent Res; 2023 Jun; 102(6):608-615. PubMed ID: 36942423
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of mouthwashes on reducing SARS-CoV-2 viral load in oral cavity: a systematic review and meta-analysis.
Ebrahimi T; Shamshiri AR; Alebouyeh M; Mohebbi SZ
BMC Oral Health; 2023 Jul; 23(1):443. PubMed ID: 37400836
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Toothpastes on SARS-CoV-2 Viral Load in Saliva.
Eduardo FP; Corrêa L; Mansur F; Benitez C; Hamerschlak N; Pinho JRR; Heller D; Bezinelli LM
Int Dent J; 2022 Dec; 72(6):825-831. PubMed ID: 35570015
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of mouthrinses in reducing oral SARS-COV-2 load: a review.
Pannuti CM; Reis INRD; Souza NV; Souto MLS; Silva CGB; Bezinelli LM; Machado CM; Romito GA; Villar CC
Braz Oral Res; 2023; 37():e038. PubMed ID: 37132726
[TBL] [Abstract][Full Text] [Related]
19. Reducing the viral load of SARS-CoV-2 in the saliva of patients with COVID-19.
Guimarães TC; Marques BBF; Castro MV; Secco DA; Porto LCMS; Tinoco JMM; Tinoco EMB; Fletcher P; Fischer RG
Oral Dis; 2022 Nov; 28 Suppl 2():2474-2480. PubMed ID: 34963033
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of chlorhexidine-based mouthwashes and its adverse events: Performance-related evaluation of mouthwashes added with Anti-Discoloration System and cetylpyridinium chloride.
Guerra F; Pasqualotto D; Rinaldo F; Mazur M; Corridore D; Nofroni I; Ottolenghi L; Nardi GM
Int J Dent Hyg; 2019 Aug; 17(3):229-236. PubMed ID: 30375179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
